Tremelimumab-actl
Generic Name: tremelimumab-actl
Manufactured by ASTRAZENECA AB. Dosage form: INJECTABLE. Route: INTRAVENOUS. Active ingredients: TREMELIMUMAB-ACTL (300MG/15ML(20MG/ML)). Application: BLA761270.
Overview
Manufactured by ASTRAZENECA AB. Dosage form: INJECTABLE. Route: INTRAVENOUS. Active ingredients: TREMELIMUMAB-ACTL (300MG/15ML(20MG/ML)). Application: BLA761270.
Dosage
Available as injectable for intravenous use.
Related Medications
Oenanthe Crocata Root
oenanthe crocata root
Uses: See symptoms on front panel. Relieves cough, sore throat *
Distichlis Spicata
distichlis spicata
Dosage form: INJECTION. Route: CUTANEOUS, INTRADERMAL, SUBCUTANEOUS. Active ingredients: DISTICHLIS SPICATA POLLEN (.05 g/mL). Category: BLA.
Dichlorphenamide
dichlorphenamide
Carbonic Anhydrase Inhibitor [EPC]
11 DESCRIPTION KEVEYIS tablets contain dichlorphenamide, an oral carbonic anhydrase inhibitor. Dichlorphenamide, a dichlorinated benzenedisulfonamide, is known chemically as 4, 5–dichloro-1,3-benzenedisulfonamide. Its empirical formula is C 6 H 6 Cl 2 N 2 O 4 S 2 and its structural formula is: Dichlorphenamide USP is a white or practically white, crystalline compound with a molecular weight of 305.16.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.